Doctor profile · Federal record
Dr. Andrew Avarbock, M.D., PH.D.
Dermatology Physician (CMS: Dermatology) · New York, NY
- NPI 1669649968
- Accepts Medicare
- 18 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
156 William St, 7Th Floor
New York, NY 100382609
(646) 962-3376 - Mailing address
-
575 Lexington Ave
New York, NY 100226102
Credentials & registration
- NPI registered
- May 2008 — 18 yrs on file
- Profile last updated
- October 15, 2013
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #257508
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1669649968. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,398
Distinct HCPCS
10
Medicare allowed
$159,278
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,765 | 174 | $7 | |
17000 |
Destruction of precancer skin growth, 1 growth | 372 | 179 | $49 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 306 | 146 | $95 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 209 | 91 | $134 | |
17110 |
Destruction of skin growth, 1-14 growths | 153 | 99 | $110 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 101 | 101 | $122 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 83 | 33 | $1 | |
11102 |
Biopsy of related skin growth, first growth | 81 | 60 | $85 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 61 | 20 | $175 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 55 | 55 | $178 |
In context: peer comparison
Among 139 peers in this city , average services per provider: 182. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$52
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $28.12 | |
| LEO Pharma Inc. | 1 | $24.19 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
492
Patients
262
Total drug cost
$20,641
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 78 | 51 | $969 |
| Ketoconazole | Generic | 66 | 32 | $1,444 |
| Clobetasol Propionate | Generic | 52 | 32 | $3,687 |
| Doxycycline Hyclate | Generic | 52 | 26 | $1,269 |
| Gabapentin | Generic | 34 | 18 | $378 |
| Finasteride | Generic | 30 | 14 | $359 |
| Metronidazole | Generic | 26 | 18 | $2,313 |
| Prednisone | Generic | 24 | 13 | $125 |
| Mupirocin | Generic | 23 | 18 | $240 |
| Clindamycin Phosphate | Generic | 21 | 0 | $1,405 |
Frequently asked questions
What is Dr. Andrew Avarbock's medical specialty?
Dr. Andrew Avarbock practices Dermatology Physician in New York, NY.
Where does Dr. Andrew Avarbock practice?
Dr. Andrew Avarbock practices at 156 William St, New York, NY 100382609. Office phone: 6469623376.
What is Dr. Andrew Avarbock's NPI?
Dr. Andrew Avarbock's National Provider Identifier (NPI) is 1669649968, issued by NPPES.
Does Dr. Andrew Avarbock accept Medicare assignment?
Yes. Dr. Andrew Avarbock accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Andrew Avarbock commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.